Novartis suspends eight CAR-T trials after three patient deaths
Novartis AG has reportedly suspended eight clinical trials of an experimental CAR-T treatment after three patients died, according to The Wall Street Journal. The trials were stopped after the company learned of the deaths in late August.
Swiss pharmaceutical giant Novartis AG (NVS, Financials) has reportedly suspended eight clinical trials of an experimental CAR-T treatment, after three patients died.In late August, Novartis stopped the trials after learning of the deaths, The Wall Street Journal said.
The trials were investigating…